Lobbying Spend
—
Filings
8
Firms Hired
1
Active Period
2020–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Speeding Therapy Access Today Act of 2021
2021 · first_quarter · Firm: THE KPM GROUP DC LLC
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Client expense: — · Firm income: $27,000
Matched citations: H.R. 1730
Speeding Therapy Access Today Act of 2021
2021 · first_quarter · Firm: THE KPM GROUP DC LLC
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Client expense: — · Firm income: $27,000
Matched citations: S. 670
Cancer Drug Parity Act of 2019
2020 · fourth_quarter · Firm: THE KPM GROUP DC LLC
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Client expense: — · Firm income: —
Matched citations: H.R. 1730
Cancer Drug Parity Act of 2019
2020 · fourth_quarter · Firm: THE KPM GROUP DC LLC
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Client expense: — · Firm income: —
Matched citations: H.R. 1730
Sunshine Protection Act of 2019
2020 · fourth_quarter · Firm: THE KPM GROUP DC LLC
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Client expense: — · Firm income: —
Matched citations: S. 670
Sunshine Protection Act of 2019
2020 · fourth_quarter · Firm: THE KPM GROUP DC LLC
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Client expense: — · Firm income: —
Matched citations: S. 670
Source: Senate LDA